title: Neutrophils cast NETs in atherosclerosis: employing peptidylarginine deiminase as a therapeutic target.
authors.affiliation: From Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Germany (Y.D., O.S., C.W.); Academic Medical Center, Department of Pathology, Amsterdam University, the Netherlands (O.S.); and DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Germany (O.S., C.W.).
authors.forename: Yvonne
authors.initials: Y
authors.lastname: Döring
authors.forename: Oliver
authors.initials: O
authors.lastname: Soehnlein
authors.forename: Christian
authors.initials: C
authors.lastname: Weber
mesh_terms: D000818:Animals; D050197:Atherosclerosis / Q000517:prevention & control*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006867:Hydrolases / Q000037:antagonists & inhibitors*; D007113:Immunity, Innate / Q000187:drug effects*; D009952:Ornithine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000080002:Protein-Arginine Deiminase Type 4
chemical_list: D004791:Enzyme Inhibitors; C558727:N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide; D009952:Ornithine; D006867:Hydrolases; D000080002:Protein-Arginine Deiminase Type 4; C552151:peptidylarginine deiminase 4, mouse
keywords: N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide; atherosclerosis; protein-arginine deiminase